The Oxford decision was made pending an analysis on the possible links between the drug and episodes of thrombosis among adults. In short, doubts remain about the safety of the British serum and we are moving towards one limitation towards young groups for the serum. The EMA takes its time, announcing a press conference by Thursday to illustrate its conclusions. Meanwhile, the EU is blocking another shipment of three million vaccines on its way to l’Australia.
The vaccines administered – In Italy, 54% of the doses of AstraZeneca have been administered to date (2,218,038 out of 4,098,800 delivered), according to the Ministry of Health, while for Moderna the percentage drops to 50% (658,403 out of 1,328,200). Pfizer, on the other hand, has an administration rate of 96%, (8,375,625 out of 8,709,480). In total in our country, out of 14,136,480 doses of the three vaccines arrived, 11,252,066 were administered, about 80%.
Popular distrust – The suspicion is growing that popular distrust weighs on AstraZeneca. In Naples, hundreds of people asked the vaccination center directly to change to Pfizer, delaying the administration. In addition, 20-30% of those booked with AstraZeneca do not show up at the Cagliari hub, especially school teachers, in a region among the worst in terms of performance, which vaccinated just 39 people at Easter.
The Lazio case – For AstraZeneca there was also a Lazio yellow, which disputed having received 98 thousand doses, as instead indicated in the national counter. The commissioner for the emergency Francesco Figliuolo replied that they were destined for law enforcement, armed forces and civil protection. Lazio also denounces a 50% cut in the delivery of the Anglo-Swedish vaccine scheduled for April 14, but in this case it is a postponement to 16 and 23, with the other arrivals.
The point about the vaccination campaign – What is certain is that the eight million doses planned in Italy this month will not be enough to vaccinate 500 thousand people a day as foreseen in the national plan. It will be necessary to focus strongly on the over 70s, an age group very neglected and very affected by deaths (six million are still waiting for the first dose, 1.5 million the second), and keep the reserve of second doses, most of the 2.8 millions in the fridge. Six million out of eight of April’s doses will be Pfizer and that’s the good news.
– .
